[1]
R. P. Surti, “Current treatment approaches for breast cancer patients with HER2-positive disease in the adjuvant, and neo-adjuvant setting”, Int J Basic Clin Pharmacol, vol. 10, no. 5, pp. 596–608, Apr. 2021.